MAM
ELV icon

Majedie Asset Management’s Elevance Health ELV Stock Holding History

Majedie Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$27.6M Sell
56,290
-12,391
-18% -$5.66M 2.26% 10
2021
Q4 		$31.9M Buy
68,681
+697
+1% +$293K 2.43% 11
2021
Q3 		$25.4M Sell
67,984
-153
-0.2% -$58.1K 1.92% 13
2021
Q2 		$26M Buy
68,137
+1,664
+3% +$636K 1.71% 13
2021
Q1 		$23.9M Buy
66,473
+18,394
+38% +$5.92M 1.73% 15
2020
Q4 		$15.5M Buy
48,079
+5,890
+14% +$1.81M 1.18% 29
2020
Q3 		$11.3M Buy
42,189
+2,736
+7% +$736K 0.84% 31
2020
Q2 		$10.4M Buy
39,453
+3,784
+11% +$1.01M 0.79% 28
2020
Q1 		$8.12M Sell
35,669
-3,141
-8% -$856K 0.75% 26
2019
Q4 		$11.7M Buy
38,810
+11,626
+43% +$3.2M 0.85% 27
2019
Q3 		$6.53M Buy
27,184
+847
+3% +$232K 0.55% 38
2019
Q2 		$7.45M Sell
26,337
-4,962
-16% -$1.36M 0.57% 37
2019
Q1 		$8.99M Sell
31,299
-18,110
-37% -$5.24M 0.63% 39
2018
Q4 		$13.3M Sell
49,409
-14,903
-23% -$4.1M 0.99% 26
2018
Q3 		$17.6M Buy
64,312
+720
+1% +$187K 1.33% 17
2018
Q2 		$15.1M Hold
63,592
– – 1.17% 16
2018
Q1 		$14M Buy
63,592
+7,623
+14% +$1.79M 1.27% 19
2017
Q4 		$12.6M Sell
55,969
-13,430
-19% -$2.86M 1.06% 24
2017
Q3 		$13.2M Sell
69,399
-16,285
-19% -$3.1M 1.07% 24
2017
Q2 		$16.1M Buy
85,684
+5,281
+7% +$949K 1.53% 12
2017
Q1 		$13.3M Buy
80,403
+22,808
+40% +$3.63M 1.42% 20
2016
Q4 		$8.28M Buy
57,595
+20,231
+54% +$2.71M 1.11% 22
2016
Q3 		$4.68M Buy
+37,364
New +$4.82M 0.75% 35

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Majedie Asset Management's ELV Position: Q1 2022 in Review

Majedie Asset Management reduced its Elevance Health (ELV) stake by 18% in Q1 2022, selling an estimated $5.66M and leaving 56,290 shares worth $27.6M. The position accounts for 2.26% of the portfolio, ranked #10.

Majedie Asset Management first reported a position in ELV in Q3 2016 and has held it in 23 quarters since. The position peaked at $31.9M in Q4 2021. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Majedie Asset Management held 56,290 shares of Elevance Health worth $27.6M as of Q1 2022.
  • Majedie Asset Management sold 12,391 Elevance Health shares in Q1 2022, an estimated $5.66M.
  • Elevance Health made up 2.26% of Majedie Asset Management's portfolio in Q1 2022, its #10 holding.
  • Majedie Asset Management first reported a position in Elevance Health in Q3 2016 and has held it in 23 quarters since.
  • Majedie Asset Management's Elevance Health position peaked at $31.9M in Q4 2021.
  • 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Majedie Asset Management's 13F filing for Q1 2022, filed 16 May 2022.